For months the U.S. public has been assured, through printed and radioed advertising blurbs, that antihistamine tablets will stop colds, kill colds, prevent colds, or save a cold sufferer from some worse illness. Many U.S. doctors have insisted that such sweeping claims were, at best, not fully proved. But sales of the little pills went right on up to tens of millions of dollars.
Last week the Federal Trade Commission, asking for a showdown, cited three leading sellers of anti-histaminics for false and misleading advertising. The complaints were issued against the Anahist Co. of...
To continue reading:
or
Log-In
